You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 64 No. 8, August 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Neurological Review
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (3)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Drug Therapy, Other
 •Behavioral Neurology
 •Review
 •Movement Disorders
 •Parkinson Disease/ Parkinsonian Disorders
 •Neurology, Other
 •Drug Therapy
 •Alert me on articles by topic

Medication-Related Impulse Control and Repetitive Behaviors in Parkinson Disease

Valerie Voon, MD; Susan H. Fox, MD, PhD

Arch Neurol. 2007;64(8):1089-1096.

A range of behaviors presumed to be related to aberrant or excessive dopaminergic medications are being increasingly recognized in Parkinson disease. These behaviors are linked by their incentive- or reward-based and repetitive natures and include pathological gambling, hypersexuality, compulsive shopping, compulsive eating, hobbyism, and compulsive medication use. Such behaviors can have potentially devastating psychosocial consequences and are often hidden. Whether these behaviors are simply related to dopaminergic medications interacting with an underlying individual vulnerability or whether the primary pathological features of Parkinson disease play a role is not known. We reviewed the literature on these behaviors in Parkinson disease, including definitions, epidemiological and potential pathophysiological features, and management. The study of these behaviors allows not only improved clinical management but also greater insight into a biologically mediated complex behavioral model.


Author Affiliations: Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland (Dr Voon); and Department of Psychiatry (Dr Voon) and Division of Neurology, Department of Medicine (Dr Fox), Toronto Western Hospital, Toronto, Ontario, Canada.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Parkinson's disease and dopaminergic therapy--differential effects on movement, reward and cognition
Rowe et al.
Brain 2008;0:awn112v1-awn112.
ABSTRACT | FULL TEXT  

Invited Article: Changing concepts in Parkinson disease: Moving beyond the Decade of the Brain
Marras and Lang
Neurology 2008;70:1996-2003.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.